zemplar 5 mikrogramov/ml injekčný roztok
abbvie s.r.o., slovensko - parikalcitol - 87 - varia i
purivist
abbvie s.r.o., slovensko - epinastín - 64 - ophthalmologica
olynth ha 0,05 %
mcneil healthcare (ireland) limited, Írsko - xylometazolín - 69 - otorhinolaryngologica
olynth ha 0,1 %
mcneil healthcare (ireland) limited, Írsko - xylometazolín - 69 - otorhinolaryngologica
skyrizi
abbvie deutschland gmbh & co. kg - risankizumab - psoriasis; arthritis, psoriatic - imunosupresíva - plaque psoriasisskyrizi is indicated for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy. psoriatic arthritisskyrizi, alone or in combination with methotrexate (mtx), is indicated for the treatment of active psoriatic arthritis in adults who have had an inadequate response or who have been intolerant to one or more disease-modifying antirheumatic drugs (dmards). crohn's diseaseskyrizi is indicated for the treatment of adult patients with moderately to severely active crohn's disease who have had an inadequate response to, lost response to, or were intolerant to conventional therapy or a biologic therapy.
duodopa sc 240 mg/ml + 12 mg/ml infúzny roztok
abbvie s.r.o., slovensko - foslevodopa a inhibítor dekarboxylázy - 27 - antiparkinsonica
aquipta
abbvie deutschland gmbh & co. kg - atogepant - poruchy migrény - aquipta is indicated for prophylaxis of migraine in adults who have at least 4 migraine days per month.
tepkinly
abbvie deutschland gmbh & co. kg - epcoritamab - lymphoma, large b-cell, diffuse - antineoplastické činidlá - tepkinly as monotherapy is indicated for the treatment of adult patients with relapsed or refractory diffuse large b-cell lymphoma (dlbcl) after two or more lines of systemic therapy.
gabbrovet multi 140 mg/ml
ceva animal health slovakia, sr - sol.
aquadog (roasted rabbit)